Infectious Diseases

pharma-news-for-gsk-idorsia-bms-novartis-lilly-cantex-viatris-biocon

Notizia - Recent Pharma, Healthcare and Biotech Happenings

GSK’s Covifenz; Idorsia’s Quviviq; GSK’s ZEJULA; EMA Expands its Nod for BMS, Eli Lilly, and Novartis Drugs; Cantex Secures Global Licence to Develop Azeliragon; Biocon Acquires Viatris’ Biosimilar Business

GSK’s Covifenz, A Plant-Based COVID Vaccine, Receives First Approval The recombinant COVID-19 vaccine developed by Medicago, now known as Covifenz, has received approval in Canada, the company's home country. Covifenz employs Coronavirus-Like Particle (CoVLP) technology, with the vaccine consisting of recombinant spike (S) glycoprotein expressed as virus-like particles co-administered with GSK's pandemic adjuvant. It can be kept refrigerated at room temperature ranging from 2 degrees Celsius (35.6 degrees Fahrenheit) to 8 degrees Celsius (46.4 degrees Fahrenheit). The vaccine is given intramuscularly in two doses, 21 days apart. Covifenz is Medicago's first approve...

Explore More...

fake-news-misinformation-in-the-healthcare-medical-health-sector

Fake News In The Healthcare Sector: A Misinformation Crisis In The Era Of Digitalization

Horizon, Viela Deal; Concert Schizophrenia Drug Flop; Gilead, Gritstone Deal

Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone

Aurinia's Lupkynis for Lupus; Toripalimab; Merck’s Covid-19 Vaccines fail

Aurinia’s Lupkynis for Lupus; FDA Fast Track Designation for Toripalimab; Wren Therapeutics’ Financing; Merck’s Covid-19 Vaccine Program End

Thrombocytopenia drugs market | Drug-Induced Thrombocytopenia

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

Birinapant licensing; AvantGen, IGM pairs up for anti-SARS-CoV-2 antibodies; BeiGene, Novartis to co-dvelop Tislelizumab; Valo raises USD190 M; Bluebird Bio Spins-off

Hepatitis D Market | Hepatitis D Treatment Market | HDV Market

FTA for Gannex’s ASC4; Disappointment for Incyte’s Ruxolitinib; Historic win for Pfizer, BioNTech’s COVID Vaccine; Alexion buyout; the debut of InnoSkel

recent-pharma-biotech-news-updates-for-astrazeneca-uniqure-csl

AstraZeneca’s COVID-19 vaccine; Type 1 diabetes research updates; FDA nod to Zebra’s X-ray modelling AI; UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3

recent-pharma-biotech-news-and-updates-for-zimmer-bayer-ovid-merck-janssen-roche

Roche’s quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acquires A&E Medical; Glaucoma research study: Merck chooses TriNKET cancer immunotherapy program; Ovid fails Angelman phase 3 study

bioterrorism-biological-attack-a-threat-to-the-healthcare-economy-society-security-and-global-peace

Bioterrorism: A Threat To The Healthcare And Global Peace

recent-pharma-news-and-updates-for-gilead-novartis-lilly-innovent

Novartis’ COVID-19 deal; Shattered hopes for Remdesivir; Lilly’s R&D pact with Precision; Innovent’s Humira Biosimilar

Albireo's PFIC Therapy; Lupin’s Trichomoniasis Drug; Moderna's COVID vaccine; NASH Cocktail Therapy

Albireo Pharma’s PFIC Therapy; Lupin’s Trichomoniasis Oral Drug; Moderna’s Weapon Against COVID; Gilead & Novo Nordisk’s Cocktail Therapy for NASH

recent-pharma-news-and-updates-for-egenesis-duke-decibel-genscript

FDA authorizes first diagnostic test for Covid-19 antibodies; EGenesis’s collaboration with Duke; Pancreatic Cancer research updates; Decibel scores $ 82 M

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Infectious Diseases

GSK’s Covifenz; Idorsia’s Quviviq; GSK’s ZEJULA; EMA Expands its Nod for BMS, Eli Lilly, and Novartis Drugs; Cantex Secures Global Licence to Develop Azeliragon; Biocon Acquires Viatris’ Biosimilar Business

Fake News In The Healthcare Sector: A Misinformation Crisis In The Era Of Digitalization

Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone

Aurinia’s Lupkynis for Lupus; FDA Fast Track Designation for Toripalimab; Wren Therapeutics’ Financing; Merck’s Covid-19 Vaccine Program End

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

Birinapant licensing; AvantGen, IGM pairs up for anti-SARS-CoV-2 antibodies; BeiGene, Novartis to co-dvelop Tislelizumab; Valo raises USD190 M; Bluebird Bio Spins-off

Increasing Prevalence and Upcoming Novel Therapeutic Approaches: What is Shaping the Hepatitis D Market Outlook?

Ikena bags $120M; Terns raises $87M for NASH; Ribometrix Genentech Collaboration; Hologic acquires Biotheranostics

Search for the Cure Continues in the Chronic Hepatitis B Treatment Market

More Views & Analysis

8 Of The Most Common Foods Allergies – Do You Have One?

FTA for Gannex’s ASC4; Disappointment for Incyte’s Ruxolitinib; Historic win for Pfizer, BioNTech’s COVID Vaccine; Alexion buyout; the debut of InnoSkel

AstraZeneca’s COVID-19 vaccine; Type 1 diabetes research updates; FDA nod to Zebra’s X-ray modelling AI; UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3

Roche’s quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acquires A&E Medical; Glaucoma research study: Merck chooses TriNKET cancer immunotherapy program; Ovid fails Angelman phase 3 study

Bioterrorism: A Threat To The Healthcare And Global Peace

Novartis’ COVID-19 deal; Shattered hopes for Remdesivir; Lilly’s R&D pact with Precision; Innovent’s Humira Biosimilar

Albireo Pharma’s PFIC Therapy; Lupin’s Trichomoniasis Oral Drug; Moderna’s Weapon Against COVID; Gilead & Novo Nordisk’s Cocktail Therapy for NASH

FDA authorizes first diagnostic test for Covid-19 antibodies; EGenesis’s collaboration with Duke; Pancreatic Cancer research updates; Decibel scores $ 82 M

Subscribe to our Updates

Daily

Weekly

Monthly